Ionis Pharmaceuticals Inc
XBER:ISI
Ionis Pharmaceuticals Inc
XBER:ISI
Price:
67.36
EUR
Market Cap:
€5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Ionis Pharmaceuticals Inc
XBER:ISI
|
US |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
A
|
Aramis Group SAS
LSE:0AAA
|
FR |
|
PLC SpA
MIL:PLC
|
IT |
|
W
|
WuXi AppTec Co Ltd
F:WX8
|
CN |
|
MRF Ltd
BSE:500290
|
IN |
|
K
|
Kadokawa Corp
OTC:KDKWF
|
JP |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Wall Street analysts forecast ISI stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ISI is 89.67 EUR with a low forecast of 41.5 EUR and a high forecast of 121.94 EUR.
Lowest Forecast
Price Target
41.5
EUR
38% Downside
Average Forecast
Price Target
89.67
EUR
33% Upside
Highest Forecast
Price Target
121.94
EUR
81% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
89.67
EUR
89.67
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 89.67 EUR with a low forecast of 41.5 EUR and a high forecast of 121.94 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
25%
25%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 25%.
